Intrathecal Morphine for Postoperative Analgesia Following Laparoscopic Bariatric Surgery
- Registration Number
- NCT02731430
- Lead Sponsor
- Assiut University
- Brief Summary
this study compares the use of intrathecal morphine, to multimodal analgesic techniques for postoperative pain management following laparoscopic bariatric surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- American Society of Anesthesia (ASA) II-III patients.
- Aged 30-50 years.
- The body mass index (BMI) of the patients needed to be over 40 kg/m² or over 35 kg/m² with at least one comorbidity.
Exclusion Criteria
- Patients with a known allergy to the study drugs.
- Advanced cardiac, respiratory, renal or hepatic disease.
- Coagulation disorders.
- Infection at or near the site of intrathecal injection.
- Drug or alcohol abuse.
- Psychiatric illnesses that may interfere with perception and assessment of pain.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description group II: control group intrathecal saline received 0.3ml saline added to 1.2mlof bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia. group I: morphine group intrathecal morphine received 0.3mg morphine (0.3ml) added to 1.2ml of bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.
- Primary Outcome Measures
Name Time Method Total postoperative analgesic consumption. 24 hours postoperative the efficacy of the studied dose of intrathecal morphine in reducing postoperative analgesic consumption.
- Secondary Outcome Measures
Name Time Method Time to first request of rescue analgesia. 24 hours postoperative Visual analogue scale (VAS) scores 24 hours postoperative postoperative pain scores
Tolerability as assessed by the incidence of side effects 24 hours postoperative the incidence of side effects